Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-119992
Filing Date
2016-05-13
Accepted
2016-05-13 16:58:58
Documents
1
Period of Report
2016-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18278
  Complete submission text file 0001209191-16-119992.txt   21334
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161649209

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161649212

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Capital GP V LLC (Reporting) CIK: 0001615374 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161649211

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 601 LEXINGTON AVENUE (AT 53RD STREET) 54TH FLOOR NEW YORK NY 02109
Business Address 601 LEXINGTON AVENUE (AT 53RD STREET) 54TH FLOOR NEW YORK NY 02109 617-570-8364
OrbiMed Global Healthcare GP LLC (Reporting) CIK: 0001673892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161649210